Publications by authors named "Caitlin Cornwall"

Claim this Profile
S
Safety and Efficacy of GFB-887, a TRPC5 Channel Inhibitor, in Patients With Focal Segmental Glomerulosclerosis, Treatment-Resistant Minimal Change Disease, or Diabetic Nephropathy: TRACTION-2 Trial Design.
Liron Walsh, John F Reilly, Caitlin Cornwall, Gregory A Gaich, Debbie S Gipson

Kidney Int Repยท October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis